Pérez-Martínez utilized nanodelivery technology to administer a specific siRNA targeting cofilin-1 to human PCa cells, downregulating cofilin-1 expression and enhancing docetaxel-induced cytotoxicity (Pérez-Martínez et al., 2012). The gene discussed is CFL1; the disease is posterior cortical atrophy.